Previous Close | 214.10 |
Open | 213.80 |
Bid | 208.10 x 0 |
Ask | 208.20 x 0 |
Day's Range | 206.20 - 214.90 |
52 Week Range | 174.20 - 275.20 |
Volume | |
Avg. Volume | 742,254 |
Market Cap | 56.844B |
Beta (5Y Monthly) | 0.58 |
PE Ratio (TTM) | 25.27 |
EPS (TTM) | 8.26 |
Earnings Date | Apr 22, 2024 |
Forward Dividend & Yield | 4.40 (2.11%) |
Ex-Dividend Date | Apr 23, 2024 |
1y Target Est | 246.89 |
Subscribe to Yahoo Finance Plus to view Fair Value for GETI-B.ST
European shares edged lower on Monday as rising government bond yields and concerns over the Israel-Hamas war kept investors on edge, while Italy's FTSE MIB index was among top gainers across the regional markets. The pan-European STOXX 600 ended 0.1% lower after declines of over 3% in the previous week. While European Union leaders are set to call for a "humanitarian pause" in the Israel-Hamas war so aid could reach them, Israel continued its bombardment of the besieged enclave.
Getinge announced today that it has acquired 100 percent of the shares in US-based Healthmark Industries Co. Inc., a leading provider of innovative instrument care and infection control consumables, for approximately USD 320 M. This strategic step enhances Getinge's presence within sterile reprocessing in the US and facilitates a global expansion for Healthmark.
Getinge announces today an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications.